Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United States Antimony (UAMY) Cash & Equivalents (2016 - 2025)

United States Antimony's Cash & Equivalents history spans 15 years, with the latest figure at $18.5 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 41.35% year-over-year to $18.5 million; the TTM value through Sep 2025 reached $18.5 million, up 41.35%, while the annual FY2024 figure was $18.2 million, 52.01% up from the prior year.
  • Cash & Equivalents for Q3 2025 was $18.5 million at United States Antimony, up from $5.8 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $23.1 million in Q1 2021 and bottomed at $5.8 million in Q2 2025.
  • The 5-year median for Cash & Equivalents is $15.4 million (2023), against an average of $15.7 million.
  • The largest annual shift saw Cash & Equivalents soared 100037.01% in 2021 before it plummeted 64.31% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $21.4 million in 2021, then decreased by 10.75% to $19.1 million in 2022, then plummeted by 37.47% to $12.0 million in 2023, then skyrocketed by 52.01% to $18.2 million in 2024, then increased by 1.64% to $18.5 million in 2025.
  • Per Business Quant, the three most recent readings for UAMY's Cash & Equivalents are $18.5 million (Q3 2025), $5.8 million (Q2 2025), and $18.7 million (Q1 2025).